WE-SPARK is in the process of building an inventory of existing facilities, as well as our gaps and needs. Please check back often.
Funding Body | Competition |
Canada Foundation for Innovation (CFI) | John R. Evans Leaders Fund (JELF) Funding provided to institutions through the JELF helps institutions to recruit and retain outstanding researchers, acquire the tools that enable the innovative work of leading researchers and offer research support that, when combined with research support from our partner organizations, is highly competitive. |
Eligible projects: Involves acquiring or developing research infrastructure to increase research capacity and support world-class research. Total projects must be greater than $1 million for proposals to be considered. | |
Goal: Supports projects that enhance the capacity of Canadian colleges to carry out applied research and technology development and foster partnerships that generate innovative products, processes or services that address the social, business, health or environmental needs of a Canadian industry or community. | |
Major Science Initiatives (MSI) Fund Facility Definition: | |
Exceptional Opportunities Fund (EOF) To qualify for this funding opportunity, a project must meet the following requirements: | |
Biosciences Research Infrastructure Fund (BRIF) Objectives: Funding through the competition for biocontainment and large-animal facilities intended to: |
We have several research pipelines that are made up of multiple core facilities and require highly trained technicians and cutting-edge equipment. These pipelines are critical in addressing regional health issues, advancing innovation and technology and driving outcomes that support a healthier community.
Pipelines | Cores Used |
---|---|
Drug Development and Screening Innovative technologies are used to test the responses of patient samples to drugs with the goal of developing more effective drugs for different diseases including cancer. |
|
Personalized Medicine Cutting-edge technologies are used to test the genomic/proteomic and epigenomic signature of patient samples with the goal of matching patients to the best treatments. |
|
Regenerative Medicine Researchers are working together to study different regenerative systems and to engineer solutions for patients including novel medical devices. |
|
Recovery and Rehabilitation Researchers across the partnership are working together to test new solutions for post-injury recovery and rehabilitation solutions |
|
Environmental Health Researchers are monitoring our external environment (land, water, soil) and testing for compounds with toxic effects to humans |
|